Company / Assets per Share
Compass Therapeutics, Inc. Assets per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.02
FY2024
5-year range
$1.02 / $2.45
FY2020-FY2024
Trend
-17.1%
vs FY2023
Sector context
#201 of 212
Health Care
What the data says
Among 212 Health Care companies, Compass Therapeutics, Inc. is in the bottom 5% for assets per share. Assets per Share has declined for 3 consecutive years, from $2.45 in FY2021 to $1.02 in FY2024.
Based on SEC 10-K filings.
1.02 in FY2024 with a 5-year CAGR of -25.8%.
Declined from $1.58 to $1.02 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -25.3%
- 5-Year CAGR
- -25.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 212This company $1.02 Sector average $294.36
▼
-99.7% below sector average
Key checks
Key Insights
- Compass Therapeutics, Inc.'s assets per share has declined for 3 consecutive years.
- In FY2024, assets per share decreased 17.1% year-over-year.
- Ranks #201 out of 212 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.02 | -17.1% |
| FY2023 | $1.23 | -22.3% |
| FY2022 | $1.58 | -35.4% |
| FY2021 | $2.45 | +45.0% |
| FY2020 | $1.69 | -62.9% |
| FY2019 | $4.54 | +90811437.9% |
| FY2018 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026